Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial
替诺福韦艾拉酚胺用于预防接受利妥昔单抗化疗的HBsAg阴性、抗-HBc阳性患者的乙型肝炎病毒再激活：一项多中心随机对照试验
期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000859
Tabataba Vakili, Sanam; Hirode, Grishma; Zahoor, Atif; Saunthar, Ahreni; Feld, Joshua B; Hansen, Bettina E; Syeda, Ambreen; Janssen, Harry L A; Kukreti, Vishal; Kuruvilla, John; Prica, Anca; Cheung, Matthew; Buckstein, Rena; Hicks, Lisa; Coffin, Carla S; Street, Lesley E; Disperati, Patricia; Chan, Kelvin K; Crump, Michael; Feld, Jordan J
